Experimental data suggest that treating AD with PPARγ agonists such as Pioglitazone, Ibuprofen, significantly decreases the levels of the proinflammatory enzymes Cyclooxygenase (COX-2) and induces Nitric oxide synthase (iNOS), thus reducing amyloid plaques in the neuronal cells. This evidence concerns the gene PPARG and Alzheimer disease.